Overview
KVP Team
Caley Castelein
Anupam Dalal
Andrew Jensen
Jim Shapiro
Dick Spalding
Venture Partners
David Bradford
Mike Chobotov
Richard Glickman
Senior Advisors
Victor Dzau
Don Ganem
Peter Hutt
Fred Moll
Thomas Weisel
|
Dr. Chobotov founded TriVascular, a medical device company focused on minimally invasive treatment of aortic aneurysms and a 2003 fund portfolio company. As President and CEO, he led TriVascular from its product and corporate conception through its private, venture, and corporate financings, and through its strategic partnership and acquisition by Boston Scientific. Dr. Chobotov is now the President and CEO of TriVascular2, a company formed following the repurchase of these assets from Boston Scientific.
As a systems engineer, Dr. Chobotov has integrated a variety
of technologies into products, developed and patented
technical solutions to challenging problems, received
technical awards, and authored technical publications.
Out of Caltech, he joined Hughes Aircraft Company as a
systems engineer for the development of a new spacecraft
product line, HS-601, which became one of the most successful
in the industry. He left Hughes to lead the design of
the Lunar Prospector spacecraft, which his firm subsequently
licensed to Lockheed Martin to build as the first NASA
Discovery mission and launch in early 1998 (and which
subsequently discovered lunar water ice).
Dr. Chobotov later was Senior Vice President of R&D
and board member at electric/hybrid vehicle developer
U.S.E.. Prior to co-founding TriVascular in 1998, he co-founded
TransMotive Technologies, an engineering and product development
consulting company with unique capabilities for computer
simulation and analysis of complex mechanical, structural,
and dynamic phenomena in a variety of industries, including
medical devices.
Dr. Chobotov received his B.S., M.S., and Ph.D. in Mechanical
Engineering from the California Institute of Technology.
|
|
